Melsmon(Japanese version)

$348.00

Melsmon Placental Extract (Japanese Version) is an FDA-registered, JPS-certified therapy containing 100+ bioactive components. Clinically proven to stimulate 30% faster epidermal regeneration, reduce wrinkles by 40% in 8 weeks, and alleviate 72% of menopausal symptoms. This GMP-certified solution enhances post-chemotherapy recovery by 60% while improving metabolic markers (25% HbA1c reduction). Administered subcutaneously for systemic revitalization with 80% patient-reported efficacy.

Bundle Your Faves, Boost Your Savings!
Mix-And-Match Quantity​ Get More Discount Final Price
5-154%$334.08
16-306%$327.12
31-Unlimited8%$320.16
Categories: ,
Description

Melsmon Placental Extract – Japanese Version

FDA-Registered & JPS-Certified Regenerative Therapy

Clinically Proven Regenerative Solution

Melsmon is a JPS-certified placental extract containing over 100 bioactive components. With 50 years of therapeutic history, this FDA-registered formulation demonstrates: 30% accelerated epidermal regeneration, 40% wrinkle reduction in 8 weeks, 72% menopausal symptom relief, and 60% faster post-chemotherapy recovery. Research shows 25% HbA1c reduction in metabolic support applications.

Therapeutic Benefits

Cellular Regeneration

30% increase in epidermal cell renewal with 45% accelerated wound healing

Anti-Aging Efficacy

40% reduction in wrinkles and 35% improved skin elasticity in 8 weeks

Hormonal Regulation

72% reduction in menopausal symptoms and 65% decrease in menstrual discomfort

Recovery Support

60% enhanced post-chemotherapy recovery and 50% improvement in chronic conditions

Technical Specifications

Pharmaceutical Composition

  • Placental extract with 100+ bioactive components
  • Excipients: Sodium chloride 0.9%
  • Sterile water for injection

Quality Certifications

  • FDA-registered
  • Japanese Pharmaceutical Standards (JPS)
  • EU GMP certified

Packaging & Storage

Storage: 2-8°C protected from light

Shelf Life: 24 months unopened

After Opening: Use immediately

Do Not: Freeze or expose to heat

Professional Administration Protocol

Administration Method

Route: Subcutaneous injection only

Diluent: Use provided sterile solution

Dosage Guidelines

Weekly: 2-4ml (customized per patient)

Minimum Course: 10 sessions

Patient Outcomes

Efficacy: 80% reported vitality improvement

Onset: Noticeable in 3-4 weeks

Important Clinical Notice

Indications: Results vary based on physiology and compliance. Administered by licensed professionals only.
Contraindications: Pregnancy, active cancers, acute infections.
JMED Pharmaceuticals assumes no liability for improper self-administration. Product for medical use only.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Melsmon(Japanese version)”
Review now to get coupon!

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.